Home :

On 25 June 2009, the Plateforme de Ressources Biologiques (PRB or Biological Resource Platform) at Pitié-Salpêtrière Hospital in Paris has been inaugurated. This new platform brings together several biobanks under the same roof: Myobank, the muscle tissue bank created by the Institut de Myologie-AFM (Myology Institute - French Muscular Dystrophy Association), the NeuroCEB EIG, a tissue bank for research into neurodegenerative diseases, and the tumour and brain tissue banks collected by AP-HP (the Public Health Organisation serving Paris). The aim is to stimulate biomedical research by providing both French and foreign research scientists with a very broad range of human biological material samples, as along with the corresponding clinical, biological and genetic information.

> To know more.

On 22 June, at the 8th annual conference of the "Société Francophone de Thérapie Cellulaire et Génique" (French-speaking Cellular and Gene Therapy Society) in Paris, Anne Galy, Généthon research director of the Inserm unit, has been presented the 2009 Biotherapy prize awarded by Thermo Fisher Scientific Inc. For 12 years, this annual prize has been presented to a French researcher leading an innovative project in the fields of cellular therapy, gene therapy or immunotherapy.

> To know more.

With no less than 8 publications in major international scientific journals in just a few weeks, Institut de Myologie (Myology Institute) research teams* have demonstrated their leading role in the progress of knowledge and the fight against neuromuscular disease. Resulting from years of work and investments made possible by Telethon donations, some of these results are helping to improve understanding of the diseases, while others provide innovative research tools and prepare future clinical trials.

> To know more.